Linifanib: Phase II data

In an open-label Phase II trial in 53 patients who previously failed treatment with Sutent sunitinib, 0.25 mg/kg

Read the full 181 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE